Vanda Pharmaceuticals (VNDA) Exchange Rate Effect (2017 - 2026)
Vanda Pharmaceuticals' (VNDA) quarterly Exchange Rate Effect came in at -$57000.0 in Q1 2026, down 216.33% year-on-year from $49000.0 in Q1 2025, and down 385.0% quarter-over-quarter from $20000.0 in Q4 2025.
Vanda Pharmaceuticals (VNDA) Exchange Rate Effect (2017 - 2026) Analysis & Trends
Vanda Pharmaceuticals has disclosed Exchange Rate Effect across 10 years of filings, most recently posting -$57000.0 for Q1 2026.
- Exchange Rate Effect for Q1 2026 came in at -$57000.0, down 216.33% year-over-year; the trailing twelve-month figure through Mar 2026 was -$83000.0 (up 17.0% YoY), and the FY2025 annual result was $23000.0, up 114.11% from the prior year.
- Exchange Rate Effect came in at -$57000.0 for Q1 2026 at Vanda Pharmaceuticals, down from $20000.0 in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $183000.0 in Q4 2022 to a low of -$202000.0 in Q4 2024.
- The 5-year median for Exchange Rate Effect is $20000.0 (2025), against an average of $6764.7.
- Peak annual rise in Exchange Rate Effect reached 993.33% in 2025, while the deepest fall reached 364.71% in 2025.
- Vanda Pharmaceuticals' Exchange Rate Effect stood at $183000.0 in 2022, then dropped by 18.03% to $150000.0 in 2023, then plunged by 234.67% to -$202000.0 in 2024, then jumped by 109.9% to $20000.0 in 2025, then tumbled by 385.0% to -$57000.0 in 2026.
- The last three Exchange Rate Effect figures came in at -$57000.0 (Q1 2026), $20000.0 (Q4 2025), and -$180000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 3.60 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -2.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -40.30 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 8.68 Mn |
| 10 | Vanda Pharmaceuticals | 345.46 Mn | 143.15 Mn | 48.56 Mn | -57,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -57,000.00 |
| Mar 31, 2026 | -57,000.00 |
| Dec 31, 2025 | 20,000.00 |
| Dec 31, 2025 | 20,000.00 |
| Sep 30, 2025 | -180,000.00 |
| Sep 30, 2025 | -180,000.00 |
| Jun 30, 2025 | 134,000.00 |
| Jun 30, 2025 | 134,000.00 |
| Mar 31, 2025 | 49,000.00 |
| Mar 31, 2025 | 49,000.00 |
| Dec 31, 2024 | -202,000.00 |
| Dec 31, 2024 | -202,000.00 |
| Sep 30, 2024 | 68,000.00 |
| Sep 30, 2024 | 68,000.00 |
| Jun 30, 2024 | -15,000.00 |
| Jun 30, 2024 | -15,000.00 |
| Mar 31, 2024 | -14,000.00 |
| Mar 31, 2024 | -14,000.00 |
| Dec 31, 2023 | 150,000.00 |
| Dec 31, 2023 | 150,000.00 |